The Global Medical Grade Polyglycolic Acid (PGA) Market was valued at USD 89.7 Million in 2024 and is projected to reach USD 134.2 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period (2024–2030). This robust growth is primarily driven by the increasing number of surgical procedures worldwide, the rising demand for advanced absorbable sutures, and the expanding applications of PGA in tissue engineering and drug delivery systems.

As the medical device industry embraces bioabsorbable polymers for safer and more effective patient outcomes, the focus intensifies on the key material science companies that are pioneering high-purity, compliant PGA production. In this blog, we profile the Top 10 Companies in the Medical Grade Polyglycolic Acid (PGA) Industry—a group of chemical innovators and healthcare specialists shaping the future of absorbable medical devices.

---

🔟 1. KUREHA CORPORATION

Headquarters: Tokyo, Japan
Key Offering: High-Purity PGA Polymer Resins (Particles, Powder)

KUREHA is a globally recognized leader in the production of medical-grade PGA, with decades of experience in polymer science. The company’s KUREHA PGA is renowned for its exceptional purity, consistent molecular weight, and excellent biocompatibility, making it the material of choice for many leading medical device manufacturers. Their products are critical components in absorbable sutures, orthopedic fixation devices, and other surgical meshes.

Innovation and Quality Initiatives:

• Continuous investment in GMP-compliant production facilities
• R&D focused on enhancing PGA degradation profiles for specific clinical applications
• Strategic partnerships with global medical device companies for co-development

Download FREE Sample Report:
Medical Grade Polyglycolic Acid (PGA) Market – View in Detailed Research Report

---

9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: Purasorb® PGA (Medical Grade)

Corbion is a leading sustainable bioplastics company with a strong foothold in the medical polymers market. Its Purasorb® PGA is a high-molecular-weight polymer designed specifically for demanding medical applications, including drug delivery and tissue engineering. Corbion’s expertise in lactic acid-based polymers complements its PGA offerings, providing a comprehensive portfolio of bioresorbable materials.

Innovation and Quality Initiatives:

• Development of tailored PGA co-polymers (e.g., PLGA) for controlled degradation rates
• Commitment to bio-based and sustainable sourcing for polymer feedstocks
• Extensive regulatory support for customers seeking market approvals

---

8️⃣ 3. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: Resomer® PGA (Pharma & Medical Device Grade)

Evonik’s Health Care business line is a major global supplier of advanced biomaterials. The Resomer® portfolio includes high-quality PGA known for its reliability and performance in critical medical applications. Evonik serves a broad customer base, from suture manufacturers to developers of complex implantable devices, offering technical support from R&D through to commercial scale-up.

Innovation and Quality Initiatives:

• Investment in new cGMP production capacity for biomaterials
• Focus on developing novel polymer compositions for next-generation medical devices
• Comprehensive testing and characterization services for regulatory compliance

---

7️⃣ 4. BMG Incorporated

Headquarters: Kyoto, Japan
Key Offering: Medical Grade PGA Powder and Granules

BMG is a specialized Japanese manufacturer with a strong focus on bio-absorbable polymers for medical use. The company produces high-purity PGA that meets stringent pharmacological standards. BMG’s materials are extensively used in Japan and across Asia for a variety of applications, contributing significantly to the regional medical device ecosystem.

Innovation and Quality Initiatives:

• Focus on ultra-pure polymer synthesis for enhanced patient safety
• Collaborations with academic institutions for advanced material research
• Expansion of production capabilities to meet growing global demand

Download FREE Sample Report:
Medical Grade Polyglycolic Acid (PGA) Market – View in Detailed Research Report

---

6️⃣ 5. Polysciences, Inc.

Headquarters: Warrington, Pennsylvania, USA
Key Offering: Research and Medical Grade PGA

Polysciences serves the life sciences and medical research communities with a wide array of high-purity chemicals and polymers. While a key supplier for R&D quantities of PGA, the company also provides materials suitable for early-stage device prototyping and pilot-scale production, playing a crucial role in the innovation pipeline.

Innovation and Quality Initiatives:

• Provision of custom synthesis services for specialized PGA formulations
• Support for academic and startup innovation in biomaterials
• Rigorous quality control to ensure batch-to-batch consistency for research

---

5️⃣ 6. Merck KGaA (Sigma-Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: PGA for Research and Development

As a premier global supplier to the scientific community, Merck offers high-quality PGA primarily targeted at research, development, and analytical applications. Its materials are essential for universities, research institutes, and companies conducting foundational studies on absorbable polymers, drug delivery systems, and tissue scaffolds.

Innovation and Quality Initiatives:

• Extensive catalog of biomaterials for scientific exploration
• Investment in analytical standards and characterization tools
• Global distribution network ensuring rapid access for researchers worldwide

---

4️⃣ 7. Lactel Absorbable Polymers (A part of DURECT Corporation)

Headquarters: Birmingham, Alabama, USA
Key Offering: Custom Absorbable Polymers including PGA-based materials

Lactel, a division of DURECT Corporation, specializes in custom absorbable polymer technology. While known for its expertise in PLGA, the company also works with PGA and its co-polymers to create tailored solutions for specific drug delivery and medical device applications, offering services from polymer design to manufacturing.

Innovation and Quality Initiatives:

• Expertise in formulating PGA for controlled-release drug delivery applications
• cGMP manufacturing capabilities for clinical and commercial supply
• Focus on creating proprietary polymer compositions with unique release profiles

---

3️⃣ 8. Ashland Global Holdings Inc.

Headquarters: Wilmington, Delaware, USA
Key Offering: Pharmaceutical Polymers and Excipients

Ashland is a leading global specialty chemicals company. Its pharmaceutical division provides a range of excipients and polymer solutions. While not a primary PGA manufacturer, Ashland’s expertise in polymer science and formulation supports the broader ecosystem for drug delivery systems where absorbable polymers like PGA are critical.

Innovation and Quality Initiatives:

• Development of composite materials combining PGA with other functional polymers
• Technical support for formulation challenges in injectable pharmaceuticals
• Strong focus on regulatory and compliance aspects of pharmaceutical ingredients

---

2️⃣ 9. Musashino Chemical Laboratory, Ltd.

Headquarters: Tokyo, Japan
Key Offering: High-Purity Glycolic Acid and Derivatives

Musashino Chemical is a key player in the glycidic acid space, which is the primary feedstock for PGA synthesis. The company’s high-purity glycolic acid is essential for producing medical-grade PGA monomer, positioning it as a critical partner in the upstream supply chain for PGA manufacturers.

Innovation and Quality Initiatives:

• Production of bio-based glycolic acid for sustainable polymer production
• Investment in purification technologies to achieve pharmaceutical-grade monomers
• Long-standing relationships with major PGA producers in Japan and globally

---

1️⃣ 10. Huizhou Foryou Medical Devices Co., Ltd.

Headquarters: Huizhou, Guangdong, China
Key Offering: PGA-based Absorbable Sutures and Meshes

Foryou Medical is a significant manufacturer of finished medical devices, particularly absorbable sutures made from PGA and other materials. As an integrated player, the company’s operations span from polymer processing to the manufacturing of final sterile medical products, contributing substantially to the market volume for PGA.

Innovation and Quality Initiatives:

• Vertical integration from polymer to finished device manufacturing
• Focus on cost-effective production to increase accessibility of advanced sutures
• Expanding portfolio of PGA-based products for various surgical specialties

Get Full Report Here:
Medical Grade Polyglycolic Acid (PGA) Market – View in Detailed Research Report

---

🏥 Outlook: The Future of Medical Grade PGA is Biocompatible and Programmable

The medical grade PGA market is undergoing a significant transformation. While traditional applications like sutures continue to dominate consumption, the industry is investing heavily in advanced material science, composite technologies, and tailored degradation profiles for next-generation medical applications.

📈 Key Trends Shaping the Market:

• Development of PGA-based co-polymers (e.g., PLGA) for customizable degradation rates
• Increasing application in orthopedic bioresorbable implants and tissue engineering scaffolds
• Growing demand in emerging economies due to improving healthcare infrastructure and surgical volumes
• R&D focus on combination products, integrating PGA with active pharmaceutical ingredients for drug-eluting devices

Get Full Report Here:
Medical Grade Polyglycolic Acid (PGA) Market – View in Detailed Research Report

The companies listed above are not only supplying a critical biomaterial—they’re enabling the next wave of minimally invasive and patient-friendly medical treatments.